Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors
Stem Cells Translational Medicine · 2023
DOI: 10.1093/stcltm/szad035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2023. Verfasst von Seung-Ah Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Diabetes Mellitus, Experimental, Insulin-Secreting Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Technology R&D Project, Strategic Center of Cell and Bio Therapy for Heart, Diabetes & Cancer, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Bone marrow-derived stem cells are self-renewing and multipotent adult stem cells that differentiate into several types of cells. Here, we investigated a unique combination of 4 differentiation-inducing factors (DIFs), including putrescine (Put), glucosamine (GlcN), nicotinamide, and BP-1-102, to develop a differentiation method for inducing mature insulin-producing cells (IPCs) and apply this method to bone marrow mononucleated cells (BMNCs) isolated from mice. BMNCs, primed with the 4 soluble DIFs, were differentiated into functional IPCs. BMNCs cultured under the defined conditions synergistically expressed multiple genes, including those for PDX1, NKX6.1, MAFA, NEUROG3, GLUT2, and insulin, related to pancreatic beta cell development and function. They produced insulin/C-peptide and PDX1, as assessed using immunofluorescence and flow cytometry. The induced cells secreted insulin in a glucose-responsive manner, similar to normal pancreatic beta cells. Grafting BMNC-derived IPCs under kidney capsules of mice with streptozotocin (STZ)-induced diabetes alleviated hyperglycemia by lowering blood glucose levels, enhancing glucose tolerance, and improving glucose-stimulated insulin secretion. Insulin- and PDX1-expressing cells were observed in the IPC-bearing graft sections of nephrectomized mice. Therefore, this study provides a simple protocol for BMNC differentiation, which can be a novel approach for cell-based therapy in diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
- Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Subin Kim, Kyong Soo Park
Förderung
- Korea Health Technology R&D Project
- Strategic Center of Cell and Bio Therapy for Heart, Diabetes & Cancer
- Korea Health Industry Development Institute
- Ministry of Health & Welfare
- Basic Science Research Program
- National Research Foundation of Korea
- Ministry of Education
- Republic of Korea
Zitieren
APA
Lee, S. A., Kim, S., Kim, S. Y., Park, J. Y., Nan, J., Park, H. S., Lee, H., Lee, Y. D., Lee, H., Kang, S., Jung, H. S., Chung, S. S., & Park, K. S. (2023). Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szad035
Vancouver
Lee SA, Kim S, Kim SY, Park JY, Nan J, Park HS, et al. Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors. Stem Cells Translational Medicine. 2023. doi:10.1093/stcltm/szad035
BibTeX
@article{Lee2023,
author = {Lee, Seung-Ah and Kim, Subin and Kim, Seog-Young and Park, Jong Yoen and Nan, Jinyan and Park, Ho Seon and Lee, Hyunsuk and Lee, Yong Deok and Lee, Hakmo and Kang, Shinae and Jung, Hye Seung and Chung, Sung Soo and Park, Kyong Soo},
title = {Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors},
journal = {Stem Cells Translational Medicine},
year = {2023},
doi = {10.1093/stcltm/szad035}
}
EUVIMED